A minimal common outcome measure set for COVID-19 clinical researchJohn C. Marshall, Halima Salisu-Kabara, Allen Cheng et al.|The Lancet Infectious Diseases|2020Cited by 1.8k
Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation ProtocolLouise Sigfrid, J. T. Scott, Thomas M Drake et al.|The Lancet Regional Health - Europe|2021Cited by 322
Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocolYaseen M. Arabi, Robert Fowler, Hanan H. Balkhy et al.|SpringerPlus|2015Cited by 206
Open source clinical science for emerging infectionsJake Dunning, J. Kenneth Baillie, Laura Merson et al.|The Lancet Infectious Diseases|2013Cited by 98
Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation ProtocolLouise Sigfrid, Thomas M Drake, Ellen Pauley et al.|medRxiv|2021Cited by 74